OLEMA PHARMACEUTICALS

Olema Oncology Announces New Preclinical KAT6 Inhibitor Data to be Presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

20 9 2023 07:29:20 提供 Nasdaq GlobeNewswire

Olema Oncology to Participate in Upcoming Investor Conferences

06 9 2023 16:30:55 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 9 2023 16:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Announces Combined Financing for Up to $180 Million

05 9 2023 07:30:49 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update

08 8 2023 16:03:07 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 8 2023 16:30:34 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at the Canaccord Genuity 43rd Annual Growth Conference

01 8 2023 08:00:10 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 7 2023 07:30:32 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 6 2023 16:30:23 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at the 2023 Jefferies Healthcare Conference

30 5 2023 16:30:43 提供 Nasdaq GlobeNewswire

Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study

11 5 2023 08:43:20 提供 Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update

09 5 2023 16:01:03 提供 Nasdaq GlobeNewswire

Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual Congress

08 5 2023 07:06:10 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 5 2023 16:30:57 提供 Nasdaq GlobeNewswire

Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual Conference

13 4 2023 16:30:48 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

04 4 2023 16:30:50 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Strategic Update

09 3 2023 16:00:17 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 3 2023 17:00:11 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at Oppenheimer 33rd Annual Healthcare Conference

02 3 2023 16:05:19 提供 Nasdaq GlobeNewswire

Olema Oncology to Participate at Upcoming Investor Conferences

21 2 2023 16:30:35 提供 Nasdaq GlobeNewswire